The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period. Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches. The emerging countries are also expected to offer strong growth opportunities for players in the market. On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growth.
Drug screening services are expected to grow at the highest CAGR during the forecast period Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories. • By sample type, urine samples are expected to dominate the market during the forecast period
The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.
North America will dominate the market during the forecast period. Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World.In 2019, North America accounted for the largest share of the drug screening market followed by Europe.
However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.
The primary interviews conducted for this report can be categorized as follows: • By Company Type - Tier 1: 57%, Tier 2: 30%, and Tier 3: 13% • By Designation - C-level: 25%, D-level: 44%, and Others: 33% • By Region - North America: 40%, Europe: 29%, Asia Pacific: 19%, and Rest of the World: 12%
List of Companies Profiled in the Report • LabCorp (US) • Alere (US) • Thermo Fisher (US) • Drägerwerk (Germany) • Quest Diagnostics (US) • Alfa Scientific Designs (US) • Lifeloc (US) • MPD, Inc. (US) • OraSure (US) • Omega Laboratories (US) • Premier Biotech (US) • Psychemedics (US) • Roche (Switzerland) • Shimadzu (Japan) • Seimens Healthineers (US) • American Bio Medica Corporation (US) • Sciteck, Inc. (US) • ACM Global Laboratories (US) • CareHealth America (US) • Clinical Reference Laboratory (US)
Research Coverage: This report provides a detailed picture of the global drug screening market.It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user, and region.
The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth.It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders.
The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers: • Market Penetration: Comprehensive information on drug screening offered by the top 20 players in the drug screeningmarket. The report analyses the drug screeningmarket by product and service, sample type, end user, and region. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions. • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening fmarket. • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Rapid Diagnostics Market Report
The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019–2025.
The global rapid diagnostics market is one of the major segments of the global in-vitro diagnostics...
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public...
The global chromatography instruments market is projected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020 at a CAGR of 5.1%. Growth in the chromatography instruments market can be attributed to increasing investments by pharma and biotech companies in R&D activities, growing demand for hyphenated chromatography techniques, and...
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. - According to the Centers for Disease Control and Prevention (CDC) reports,...
The chiral chromatography columnmarketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is creating demand opportunities for the chiral chromatography column industry. Also,increasing...
Cardiac Marker Tests - Medical Devices Pipeline Assessment, 2020
Medical Devices sector report, “Cardiac Marker Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Marker Tests pipeline products with comparative analysis of the products...
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...
Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020
Medical Devices sector report, “Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products...
Bacteriology Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020
Medical Devices sector report, “Bacteriology Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with...
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.